CNCR vs. XHS

Last updated Jul 17, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and XHS (SPDR S&P Health Care Services ETF) are both Health & Biotech Equities funds - CNCR tracks the Loncar Cancer Immunotherapy Index while XHS tracks the S&P Health Care Services Select Industry Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.35%/yr for XHS.

Performance

CNCR vs. XHS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and SPDR S&P Health Care Services ETF (XHS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

XHS

• 1D: 0.45%
• 1M: 10.64%
• 6M: 21.53%
• YTD: 26.76%
• 1Y: 45.58%
• 3Y*: 13.33%
• 5Y*: 4.53%
• 10Y*: 9.10%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. XHS - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
XHS SPDR S&P Health Care Services ETF	27.99%

CNCR vs. XHS - Sectors Allocation Comparison

Sectors	CNCR	XHS
Healthcare	96.6%	95.7%
Financial Services	3.3%	3.7%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	0.5%
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. XHS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

XHS

XHS Risk / Return Rank: 88
XHS Sharpe Ratio Rank: 92
XHS Sortino Ratio Rank: 90
XHS Omega Ratio Rank: 89
XHS Calmar Ratio Rank: 86
XHS Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. XHS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and SPDR S&P Health Care Services ETF (XHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNCR	XHS	Difference
Sharpe ratio: Return per unit of total volatility	—	2.56	—
Sortino ratio: Return per unit of downside risk	—	3.42	—
Omega ratio: Gain probability vs. loss probability	—	1.45	—
Calmar ratio: Return relative to maximum drawdown	—	3.82	—
Martin ratio: Return relative to average drawdown	—	13.16	—

Drawdowns

CNCR vs. XHS - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum XHS drawdown of -39.32%. Use the drawdown chart below to compare losses from any high point for CNCR and XHS.

Drawdown Indicators

	CNCR	XHS	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-39.32%	+39.32%
Max Drawdown (1Y) Largest decline over 1 year	—	-11.99%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-17.81%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-31.34%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-39.32%	—
Current Drawdown Current decline from peak	0.00%	-1.72%	+1.72%
Average Drawdown Average peak-to-trough decline	0.00%	-10.12%	+10.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.48%	—

Volatility

Volatility by Period

	CNCR	XHS	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	5.41%	—
Volatility (6M) Calculated over the trailing 6-month period	—	12.81%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	17.91%	-17.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	21.22%	-21.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	22.40%	-22.40%

CNCR vs. XHS - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than XHS's 0.35% expense ratio.

Dividends

CNCR vs. XHS - Dividend Comparison

CNCR has not paid dividends to shareholders, while XHS's dividend yield for the trailing twelve months is around 0.20%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
XHS SPDR S&P Health Care Services ETF	0.20%	0.27%	0.38%	0.23%	0.19%	0.20%	0.23%	2.37%	0.34%	0.22%	0.28%	0.93%

Frequently Asked Questions

Which ETF is better, CNCR or XHS?

On fees, XHS is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or XHS?

XHS is cheaper with a 0.35% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or XHS?

XHS has the higher dividend yield at 0.20%, compared with 0.00% for CNCR.

What is the main difference between CNCR and XHS?

CNCR tracks Loncar Cancer Immunotherapy Index, while XHS tracks S&P Health Care Services Select Industry Index. They also come from different issuers: Exchange Traded Concepts and State Street. Their fees differ too: 0.79% for CNCR and 0.35% for XHS.